• Bursa Securities will suspend trading in LYC Healthcare securities on October 27, 2026, with delisting scheduled for October 29, 2026.
• The company breached ACE Market listing requirements by failing to appoint a replacement sponsor following UOB Kay Hian’s termination on October 16, 2026.
• It plans to appeal the delisting by the October 26, 2026 deadline; late appeals will not be considered.
• A timely appeal would defer delisting pending a decision, but trading would remain subject to suspension on October 27, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LYC Healthcare Bhd published the original content used to generate this news brief via Bursa Malaysia (KLSE) (Ref. ID: 3716802) on October 20, 2026, and is solely responsible for the information contained therein.